Assessing Adequate Treatment Response in Patients With Rheumatoid Arthritis

被引:7
作者
Bergman, Martin Jan [1 ,2 ]
机构
[1] Taylor Hosp, Dept Rheumatol, Ridley Pk, PA USA
[2] Drexel Univ, Coll Med, Dept Med, Philadelphia, PA 19104 USA
关键词
ANTITUMOR-NECROSIS-FACTOR; QUALITY-OF-LIFE; MODIFYING ANTIRHEUMATIC DRUGS; ANTI-TNF THERAPY; RECEIVING CONCOMITANT METHOTREXATE; COSTIMULATION MODULATOR ABATACEPT; ALPHA MONOCLONAL-ANTIBODY; STEP-DOWN PREDNISOLONE; DISEASE-ACTIVITY INDEX; 5-YEAR FOLLOW-UP;
D O I
10.1016/j.clinthera.2009.06.005
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Background: Rheumatoid arthritis (RA) presents a substantial socioeconomic burden that is potentially; reduced by Individualized, appropriate management strategies. Integral to Such strategies is recognizing the need for treatment changes when patients Inadequately), respond or do not respond to treatment. However, there might be little or no agreement as to what constitutes treatment failure or ail adequate response. Currently used American College of Rheumatology response criteria and the disease activity score may underestimate the magnitude of treatment failure When applied in clinical practice, and, having been designed to differentiate responses between large groups, the), may be of limited value in monitoring individual patients. Objective: The aim of this commentary was to assess how treatment failure and clinical remission/response have been defined In clinical Studies. Methods: A PubMed search (1948-2009) was conducted to identify clinical Studies or reviews containing the following search terms: rheumatoid arthritis and treatment failure, inadequate response, biologic therapy, DMARD, radiographic response, and remission. Select clinical reports in patients with RA were Included if remission or treatment failure, radiographic or other, was a Study end point. Results: Thirty-three studies were identified. The present assessment found no consensus as to what represents a practical definition of treatment failure or clinical remission ill the Clinical Studies assessed. The definitions varied from the complete absence of any clinical disease to computer-generated numeric scales. The variability ill clinical definitions of treatment failure or remission seems to have been mainly, attributed to the time at which assessments were made, making it difficult to detcrinine what treatment failure or remission means ill individual patients with RA in clinical practice. Conclusions: Based oil the findings of the present commentary, standard definitions of treatment failure or clinical remission/response are needed. Aggressive treatment strategies with specific clinical goals may result Ill better long-term outcomes. Early evidence of treatment effect may serve to improve clinical Outcomes, Including remission, and help define and all(Ill treatment goals in patients with RA. (Clin Ther. 2009;31:1219-1231) (C) 2009 Excerpta Medica Inc.
引用
收藏
页码:1219 / 1231
页数:13
相关论文
共 95 条
[1]
*ABB LAB, 2008, HUM AD PACK INS
[2]
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score [J].
Aletaha, D ;
Nell, VP ;
Stamm, T ;
Uffmann, M ;
Pflugbeil, S ;
Machold, K ;
Smolen, JS .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) :R796-R806
[3]
ALETAHA D, 2000, CLIN EXP RHEUMAT S39, V23, pS100
[4]
Allaart CF, 2007, J RHEUMATOL, V34, P25
[5]
*AMG, 2006, KIN AN PACK INS
[6]
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility (vol 66, pg 56, 2007) [J].
Bakker, M. F. ;
Jacobs, J. W. G. ;
Verstappen, S. M. M. ;
Bijlsma, J. W. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (01) :140-140
[7]
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility [J].
Bakker, M. F. ;
Jacobs, J. W. G. ;
Verstappen, S. M. M. ;
Bijlsma, J. W. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 :56-60
[8]
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].
Bathon, JM ;
Martin, RW ;
Fleischmann, RM ;
Tesser, JR ;
Schiff, MH ;
Keystone, EC ;
Genovese, MC ;
Wasko, MC ;
Moreland, LW ;
Weaver, AL ;
Markenson, J ;
Finck, BK .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593
[9]
*BIOG ID INC GEN U, 2008, RIT RIT PACK INS
[10]
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].
Boers, M ;
Verhoeven, AC ;
Markusse, HM ;
vandeLaar, MAFJ ;
Westhovens, R ;
vanDenderen, JC ;
vanZeben, D ;
Dijkmans, BAC ;
Peeters, AJ ;
Jacobs, P ;
vandenBrink, HR ;
Schouten, HJA ;
vanderHeijde, DMFM ;
Boonen, A ;
vanderLinden, S .
LANCET, 1997, 350 (9074) :309-318